Delivra Health Correlations
| DHBUF Stock | USD 0.01 0 10.24% |
The current 90-days correlation between Delivra Health Brands and Green Cures Botanical is -0.09 (i.e., Good diversification). The correlation of Delivra Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Delivra Health Correlation With Market
Good diversification
The correlation between Delivra Health Brands and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Delivra Health Brands and DJI in the same portfolio, assuming nothing else is changed.
Delivra |
The ability to find closely correlated positions to Delivra Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Delivra Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Delivra Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Delivra Health Brands to buy it.
Moving together with Delivra OTC Stock
| 0.64 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.68 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.63 | HLNCF | Haleon plc | PairCorr |
| 0.69 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.61 | PFE | Pfizer Inc Aggressive Push | PairCorr |
Moving against Delivra OTC Stock
| 0.68 | WMT | Walmart Aggressive Push | PairCorr |
| 0.38 | GMNFF | GobiMin | PairCorr |
| 0.74 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.68 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.63 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.57 | T | ATT Inc Aggressive Push | PairCorr |
| 0.53 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.41 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.36 | HD | Home Depot | PairCorr |
Related Correlations Analysis
| 0.13 | 0.0 | 0.0 | 0.0 | 0.01 | GRCU | ||
| 0.13 | 0.0 | 0.0 | 0.0 | 0.31 | GXXY | ||
| 0.0 | 0.0 | 0.0 | -1.0 | 0.0 | INQD | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | SPBBF | ||
| 0.0 | 0.0 | -1.0 | 0.0 | 0.0 | BHHKF | ||
| 0.01 | 0.31 | 0.0 | 0.0 | 0.0 | LRSV | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Delivra OTC Stock performing well and Delivra Health OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Delivra Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GRCU | 37.92 | 10.96 | 0.20 | (3.51) | 25.99 | 100.00 | 150.00 | |||
| GXXY | 3.20 | (0.29) | 0.00 | (0.29) | 0.00 | 12.97 | 67.08 | |||
| INQD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SPBBF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BHHKF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| LRSV | 7.19 | 0.43 | 0.00 | 0.23 | 0.00 | 0.00 | 150.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Delivra Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Delivra Health Corporate Management
Elected by the shareholders, the Delivra Health's board of directors comprises two types of representatives: Delivra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delivra. The board's role is to monitor Delivra Health's management team and ensure that shareholders' interests are well served. Delivra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delivra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gord Davey | CEO Pres | Profile | |
| Ann Gallery | Sr Communications | Profile | |
| CPA CMA | CFO Sec | Profile | |
| Matthew Wagar | VP Innovation | Profile | |
| Will Stewart | Sr Affairs | Profile | |
| CPA CGA | VP Fin | Profile | |
| Jonathan Hartshorn | Pres Satipharm | Profile |